Mettler-Toledo International Inc. (MTD)

Bamco Inc. NY decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 14.9% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 238,933 shares of the medical instruments supplier's stock after selling 41,992 shares during the period. Mettler-Toledo International accounts for

Frontier Capital Management Co. LLC cut its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 5.9% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,452 shares of the medical instruments supplier's stock after selling 1,986 shares during the period. Frontier

Daiwa Securities Group Inc. decreased its position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 26.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,673 shares of the medical instruments supplier's stock after selling 1,641 shares during the period.

Mettler-Toledo International Inc. (MTD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Mettler-Toledo International Inc. (MTD) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cetera Investment Advisers boosted its position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 8.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,335 shares of the medical instruments supplier's stock after purchasing an additional 104

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Mettler-Toledo International Inc. (NYSE: MTD). “You've got a good one there,” he added.

COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2 at 9:10 a.m. EST, and at the Citi 2025 Global Healthcare Conference on Wednesday, December 3 at 10:30 a.m. EST. A live webcast of the presentations will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and s.

Acadian Asset Management LLC increased its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 12.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,823 shares of the medical instruments supplier's stock after acquiring an additional 310 shares during

Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

MTD posted stronger-than-expected Q3 results, lifted by segment growth and solid guidance for 2025 and 2026.

Mettler-Toledo International Inc. ( MTD ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Adam Uhlman - Head of Investor Relations Patrick Kaltenbach - President & CEO Shawn Vadala - Chief Financial Officer Conference Call Participants Luke Sergott - Barclays Bank PLC, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Brandon Couillard - Wells Fargo Securities, LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Douglas Schenkel - Wolfe Research, LLC Michael Ryskin - BofA Securities, Research Division Jack Melick - Jefferies LLC, Research Division Joshua Waldman - Cleveland Research Company LLC Joshua Montpas - Robert W. Baird & Co. Incorporated, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Presentation Operator Hello, and thank you for standing by.

Mettler-Toledo (MTD) came out with quarterly earnings of $11.15 per share, beating the Zacks Consensus Estimate of $10.62 per share. This compares to earnings of $10.21 per share a year ago.

COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced third quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 6% compared with the prior year. Net earnings per diluted share as reported (EPS) were $10.57, compared with $9.96 in the prior-year period. Adjusted EPS was $11.15, an increase of 9% over the prior-year amount of $10.21. Adjusted EPS is a non-.

Besides Wall Street's top-and-bottom-line estimates for Mettler-Toledo (MTD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.